Overview

Patients are our number one priority. Founded in 2018, Reinvent Pharma’s goal is to improve the life of cancer patients by making immuno and targeted therapies more effective and affordable to all. These revolutionary new therapies are replacing years of chemo and radiation as the only viable option for most patients to treat cancer. However, still only a minority of cancer patients benefit. These new technologies are suffering from major clinical and commercial unmet needs and as a result therapies aren’t being exploited to reach their full effectiveness. Reinvent Pharma is addressing the gap. Our passion-driven team of experts are developing a new type of treatment based on a combination of FDA approved drugs to improve the effectiveness and response of these new therapies. Our technology broadens the reach of these new treatments to more cancer patients and type as well as decreasing the financial burden associated with them. Initially, we are focused on solid tumors like, liver, pancreatic, bile duct and brain cancer because these cancer types are clinically challenging and have yet to care immune and targeted therapeutic success. Our novel re-positioning combination approach will take the current revolution of therapy across the finish line by offering rapid development and integrated tools that select optimal solutions so, that all cancer patients can profit. Our Goal To transform the lives of cancer patients, by making immunotherapy and targeted therapies effective and affordable to all. Our Vision A world where cancer will be considered a chronic disease and treated by targeted and immune-based therapeutics supplemented with off-shelf medicine.